MARINOMED BIOTECH AG

21,50 EUR 0,40 (+1,90%)
Bid 21,50 EUR
Ask 22,30 EUR

Firmenbeschreibung

Die Marinomed Biotech AG ist ein österreichisches biopharmazeutisches Unternehmen, das sich auf die Entwicklung innovativer Produkte im Bereich Atemwegs- und Augenerkrankungen spezialisiert, die auf patentgeschützter Technologieplattformen basieren. Das Unternehmen ging 2006 aus einem Spinoff der Veterinärmedizinischen Universität Wien hervor. Die Marinomed Biotech AG ist in der Forschung und Entwicklung tätig und erwirtschaftet Erlöse über die Technologieplattformen und dem Vertrieb der Produkte. Das Unternehmen entwickelte bisher die Plattform Carragelose® sowie die Marinosolv®-Technologieplattform. Carragelose® wird in verschiedenen Produkten zur Behandlung von viralen Infektionen der Atemwege eingesetzt, die nahezu weltweit über Partner vertrieben werden. Mit Marinosolv® kann die Wirksamkeit schwer löslicher Wirkstoffe verbessert werden.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Free float (65.3%),Herman Unger (8.2%),Andreas Grassauer (8%),Eva Prieschl-Grassauer (8%),Abdulmohsen Al Sheikh (5.2%),Mohammed Al Sheikh (5.2%)
sharesOutstanding: 1506162.0000
ceo: Andreas Grassauer
board: Pascal Schmidt, Eva Prieschl-Grassauer
supervisoryBoard: Simon Nebel, Ute Lassnig, Brigitte Ederer, Elisabeth Lackner, Gernot Hofer, Ulrich Kinzel
countryID: 1
faceValue: 1.0000
faceValueCurrencyID: 1
faceValueCurrency: EUR
sectorName: Pharmazeutische Industrie
industryName: Gesundheitswesen
subsectorName: Pharmazeutische Industrie
country: Österreich
countryName: Österreich

Kontakt

name: Stephanie Kniep
email: ir@marinomed.com
irWebSite: https://dh3p7.app.goo.gl/nrar

Adresse

street: Hovengasse 25
city: A-2100 Korneuburg
phone: +43-2262-90300
webSite: https://www.marinomed.com/de/
email: office@marinomed.com

Finanzen (kurz)

year: 2020 cash: 9.2000
balanceSheetTotal: 23.5000 liabilities: 18.1000
totalShareholdersEquity: 5.4000 sales: 8.1000
bankLoans: -5.4000 investment: 0.5000
incomeBeforeTaxes: -6.0000 netIncome: -6.0000
cashFlow: -2.8000 employees: 42
currencyID: 1 units: 1000000
currency: EUR
year: 2021 cash: 5.8000
balanceSheetTotal: 21.3000 liabilities: 21.1000
totalShareholdersEquity: 0.2000 sales: 11.6000
bankLoans: -3.5000 investment: 0.0000
incomeBeforeTaxes: -5.7000 netIncome: -5.9000
cashFlow: -3.4000 employees: 47
currencyID: 1 units: 1000000
currency: EUR
year: 2022 cash: 8.2000
balanceSheetTotal: 22.3000 liabilities: 26.5000
totalShareholdersEquity: -4.1500 sales: 11.2700
investment: 1.2000 incomeBeforeTaxes: -6.4000
netIncome: -6.4000 employees: 49
currencyID: 1 units: 1000000
currency: EUR

Finanzen (kurz)

year: 2020
cash: 9.2000
balanceSheetTotal: 23.5000
liabilities: 18.1000
totalShareholdersEquity: 5.4000
sales: 8.1000
bankLoans: -5.4000
investment: 0.5000
incomeBeforeTaxes: -6.0000
netIncome: -6.0000
cashFlow: -2.8000
employees: 42
currencyID: 1
units: 1000000
currency: EUR
year: 2021
cash: 5.8000
balanceSheetTotal: 21.3000
liabilities: 21.1000
totalShareholdersEquity: 0.2000
sales: 11.6000
bankLoans: -3.5000
investment: 0.0000
incomeBeforeTaxes: -5.7000
netIncome: -5.9000
cashFlow: -3.4000
employees: 47
currencyID: 1
units: 1000000
currency: EUR
year: 2022
cash: 8.2000
balanceSheetTotal: 22.3000
liabilities: 26.5000
totalShareholdersEquity: -4.1500
sales: 11.2700
investment: 1.2000
incomeBeforeTaxes: -6.4000
netIncome: -6.4000
employees: 49
currencyID: 1
units: 1000000
currency: EUR

Finanzen (ausführlich)

year: 2021 units: 1000000
balanceSheetTotal: 21.3000 cash: 5.8000
currentAssets: 12.9000 liabilities: 6.0000
totalLiabilitiesEquity: 21.3000 totalShareholdersEquity: 0.2000
employees: 47 property: 6.4000
intangibleAssets: 2.0000 inventories: 1.0000
accountsPayable: 2.0000 liabilitiesBanks: 15.9000
liabilitiesTotal: 21.1000 longTermDebt: 15.1000
shortTermDebt: 0.8000 sales: 11.6000
depreciation: 0.6000 netIncome: -5.9000
operatingResult: -4.1000 ebitda: -3.5000
incomeInterest: -1.5000 incomeTaxes: 0.2000
materialCosts: 10.2000 personnelCosts: 4.4600
costGoodsSold: 14.6600 grossProfit: -3.0600
revenuePerEmployee: 178461.5385 cashFlow: -4.9000
cashFlowInvesting: -0.9000 cashFlowFinancing: 2.4000
cashFlowTotal: -3.4000 accountingStandard: IFRS
equityRatio: 0.9390 debtEquityRatio: 10550.0000
liquidityI: 96.6667 liquidityII: 96.6667
netMargin: -50.8621 grossMargin: -26.3793
cashFlowMargin: -42.2414 ebitMargin: -35.3448
ebitdaMargin: -30.1724 preTaxROE: -2850.0000
preTaxROA: -26.7606 roe: -2950.0000
roa: -27.6995 netIncomeGrowth: -1.6667
revenuesGrowth: 43.2099 taxExpenseRate: -3.5088
equityTurnover: 58.0000 epsBasic: -4.0000
epsDiluted: -4.0000 epsBasicGrowth: -2.4390
shareCapital: 1.4800 incomeBeforeTaxes: -5.7000
priceCashFlowRatio: -26.5078 dividendYield: 0.0000
bookValuePerShare: 0.1355 marketCap: 129888000.0000
earningsYield: -4.5455 cashFlowPerShare: -3.3198
priceBookValueRatio: 649.4400 dividendsPerShare: 0.0000
netEarningsPerShare: -3.9973 currency: EUR
year: 2022 units: 1000000
balanceSheetTotal: 22.3000 cash: 8.2000
currentAssets: 14.3000 liabilities: 6.0000
nonCurrentLiabilities: 20.5000 totalLiabilitiesEquity: 22.3000
totalShareholdersEquity: -4.1500 employees: 49
property: 6.2000 intangibleAssets: 1.8000
inventories: 1.6000 accountsReceivable: 4.5200
accountsPayable: 1.2000 liabilitiesTotal: 26.5000
longTermDebt: 20.1800 shortTermDebt: 2.4400
minorityInterests: 0.0000 sales: 11.2700
depreciation: 0.7000 netIncome: -6.4000
operatingResult: -4.9100 incomeInterest: -1.5000
incomeTaxes: 0.0060 costGoodsSold: 14.0000
grossProfit: -2.7300 revenuePerEmployee: 230000.0000
cashFlow: -5.2000 cashFlowInvesting: -0.2000
cashFlowFinancing: 7.8000 accountingStandard: IFRS
equityRatio: -18.6099 liquidityI: 136.6667
liquidityII: 212.0000 netMargin: -56.7879
grossMargin: -24.2236 cashFlowMargin: -46.1402
ebitMargin: -43.5670 ebitdaMargin: 0.0000
preTaxROA: -28.6996 roa: -28.6996
netIncomeGrowth: 8.4746 revenuesGrowth: -2.8448
taxExpenseRate: -0.0937 epsBasic: -4.3000
epsBasicGrowth: 7.5000 priceCashFlowRatio: -16.3361
bookValuePerShare: -2.7553 marketCap: 84947536.8000
earningsYield: -7.6241 cashFlowPerShare: -3.4525
netAssetsPerShare: -2.7553 priceBookValueRatio: -20.4693
netEarningsPerShare: -4.2492 currency: EUR
year: 2023 priceCashFlowRatio: -6.3433
bookValuePerShare: -2.7553 marketCap: 32984947.2254
earningsYield: -19.6347 pegRatio: -0.6791
cashFlowPerShare: -3.4525 netAssetsPerShare: -2.7553
priceBookValueRatio: -7.9482 netEarningsPerShare: -4.2492
currency: EUR

Finanzen (ausführlich)

year: 2021
units: 1000000
balanceSheetTotal: 21.3000
cash: 5.8000
currentAssets: 12.9000
liabilities: 6.0000
totalLiabilitiesEquity: 21.3000
totalShareholdersEquity: 0.2000
employees: 47
property: 6.4000
intangibleAssets: 2.0000
inventories: 1.0000
accountsPayable: 2.0000
liabilitiesBanks: 15.9000
liabilitiesTotal: 21.1000
longTermDebt: 15.1000
shortTermDebt: 0.8000
sales: 11.6000
depreciation: 0.6000
netIncome: -5.9000
operatingResult: -4.1000
ebitda: -3.5000
incomeInterest: -1.5000
incomeTaxes: 0.2000
materialCosts: 10.2000
personnelCosts: 4.4600
costGoodsSold: 14.6600
grossProfit: -3.0600
revenuePerEmployee: 178461.5385
cashFlow: -4.9000
cashFlowInvesting: -0.9000
cashFlowFinancing: 2.4000
cashFlowTotal: -3.4000
accountingStandard: IFRS
equityRatio: 0.9390
debtEquityRatio: 10550.0000
liquidityI: 96.6667
liquidityII: 96.6667
netMargin: -50.8621
grossMargin: -26.3793
cashFlowMargin: -42.2414
ebitMargin: -35.3448
ebitdaMargin: -30.1724
preTaxROE: -2850.0000
preTaxROA: -26.7606
roe: -2950.0000
roa: -27.6995
netIncomeGrowth: -1.6667
revenuesGrowth: 43.2099
taxExpenseRate: -3.5088
equityTurnover: 58.0000
epsBasic: -4.0000
epsDiluted: -4.0000
epsBasicGrowth: -2.4390
shareCapital: 1.4800
incomeBeforeTaxes: -5.7000
priceCashFlowRatio: -26.5078
dividendYield: 0.0000
bookValuePerShare: 0.1355
marketCap: 129888000.0000
earningsYield: -4.5455
cashFlowPerShare: -3.3198
priceBookValueRatio: 649.4400
dividendsPerShare: 0.0000
netEarningsPerShare: -3.9973
currency: EUR
year: 2022
units: 1000000
balanceSheetTotal: 22.3000
cash: 8.2000
currentAssets: 14.3000
liabilities: 6.0000
nonCurrentLiabilities: 20.5000
totalLiabilitiesEquity: 22.3000
totalShareholdersEquity: -4.1500
employees: 49
property: 6.2000
intangibleAssets: 1.8000
inventories: 1.6000
accountsReceivable: 4.5200
accountsPayable: 1.2000
liabilitiesTotal: 26.5000
longTermDebt: 20.1800
shortTermDebt: 2.4400
minorityInterests: 0.0000
sales: 11.2700
depreciation: 0.7000
netIncome: -6.4000
operatingResult: -4.9100
incomeInterest: -1.5000
incomeTaxes: 0.0060
costGoodsSold: 14.0000
grossProfit: -2.7300
revenuePerEmployee: 230000.0000
cashFlow: -5.2000
cashFlowInvesting: -0.2000
cashFlowFinancing: 7.8000
accountingStandard: IFRS
equityRatio: -18.6099
liquidityI: 136.6667
liquidityII: 212.0000
netMargin: -56.7879
grossMargin: -24.2236
cashFlowMargin: -46.1402
ebitMargin: -43.5670
ebitdaMargin: 0.0000
preTaxROA: -28.6996
roa: -28.6996
netIncomeGrowth: 8.4746
revenuesGrowth: -2.8448
taxExpenseRate: -0.0937
epsBasic: -4.3000
epsBasicGrowth: 7.5000
priceCashFlowRatio: -16.3361
bookValuePerShare: -2.7553
marketCap: 84947536.8000
earningsYield: -7.6241
cashFlowPerShare: -3.4525
netAssetsPerShare: -2.7553
priceBookValueRatio: -20.4693
netEarningsPerShare: -4.2492
currency: EUR
year: 2023
priceCashFlowRatio: -6.3433
bookValuePerShare: -2.7553
marketCap: 32984947.2254
earningsYield: -19.6347
pegRatio: -0.6791
cashFlowPerShare: -3.4525
netAssetsPerShare: -2.7553
priceBookValueRatio: -7.9482
netEarningsPerShare: -4.2492
currency: EUR